Stocks and Investing
Stocks and Investing
Mon, September 24, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, September 21, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Alethia Young Initiated (ADVM) at Buy and Held Target at $120 on, Sep 21st, 2018
Alethia Young of Cantor Fitzgerald, Initiated "Adverum Biotechnologies, Inc." (ADVM) at Buy and Held Target at $120 on, Sep 21st, 2018.
Alethia has made no other calls on ADVM in the last 4 months.
There is 1 other peer that has a rating on ADVM. Out of the 1 peers that are also analyzing ADVM, 0 agree with Alethia's Rating of Hold.
This is the rating of the analyst that currently disagrees with Alethia
- Edward Nash of "SunTrust Robinson Humphrey" Initiated at Strong Buy and Held Target at $110 on, Thursday, August 30th, 2018